BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 20723652)

  • 1. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and ventricular tachycardia.
    Chu AF; Zado E; Marchlinski FE
    Am J Cardiol; 2010 Sep; 106(5):720-2. PubMed ID: 20723652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of the ablation of atrial flutter in patients with and without a clinical history of paroxysmal atrial fibrillation].
    De Sisti A; Leclercq JF; Fiorello P; Palamara A; Attuel P
    G Ital Cardiol; 1998 Nov; 28(11):1253-60. PubMed ID: 9866803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
    Corrado D; Leoni L; Link MS; Della Bella P; Gaita F; Curnis A; Salerno JU; Igidbashian D; Raviele A; Disertori M; Zanotto G; Verlato R; Vergara G; Delise P; Turrini P; Basso C; Naccarella F; Maddalena F; Estes NA; Buja G; Thiene G
    Circulation; 2003 Dec; 108(25):3084-91. PubMed ID: 14638546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
    Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias.
    Luria DM; Hodge DO; Monahan KH; Haroldson JM; Shen WK; Asirvatham SJ; Hammill SC; Munger TM; Glikson M; Gersh BJ; Packer DL; Friedman PA
    J Cardiovasc Electrophysiol; 2008 Nov; 19(11):1145-50. PubMed ID: 18554204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation.
    Dasari TW; Pavlovic-Surjancev B; Patel N; Williams AA; Ezidinma P; Rupani A; Sinacore JL; Heroux AL
    Am J Cardiol; 2010 Sep; 106(5):737-41. PubMed ID: 20723655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Roguin A; Bomma CS; Nasir K; Tandri H; Tichnell C; James C; Rutberg J; Crosson J; Spevak PJ; Berger RD; Halperin HR; Calkins H
    J Am Coll Cardiol; 2004 May; 43(10):1843-52. PubMed ID: 15145110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of atrial arrhythmias in patients with ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy.
    Zado ES; Garg L; Tschabrunn C; Santangeli P; Hyman M; Kumareswaran R; Arkles J; Marchlinski FE
    Heart Rhythm; 2024 Feb; 21(2):133-140. PubMed ID: 37956774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical study of 39 Chinese patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Ma KJ; Li N; Wang HT; Chu JM; Fang PH; Yao Y; Ma J; Hua W; Zhang S; Wang FZ; Li Z; Pu JL
    Chin Med J (Engl); 2009 May; 122(10):1133-8. PubMed ID: 19493458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy: arrhythmia-free survival after endo-epicardial substrate based mapping and ablation.
    Bai R; Di Biase L; Shivkumar K; Mohanty P; Tung R; Santangeli P; Saenz LC; Vacca M; Verma A; Khaykin Y; Mohanty S; Burkhardt JD; Hongo R; Beheiry S; Dello Russo A; Casella M; Pelargonio G; Santarelli P; Sanchez J; Tondo C; Natale A
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):478-85. PubMed ID: 21665983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
    Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
    Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency ablation of the ventricular tachycardia with arrhythmogenic right ventricular cardiomyopathy using non-contact mapping.
    Yao Y; Zhang S; He DS; Zhang K; Hua W; Chu J; Pu J; Chen K; Wang F; Chen X
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):526-33. PubMed ID: 17437577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.
    Wichter T; Paul M; Wollmann C; Acil T; Gerdes P; Ashraf O; Tjan TD; Soeparwata R; Block M; Borggrefe M; Scheld HH; Breithardt G; Böcker D
    Circulation; 2004 Mar; 109(12):1503-8. PubMed ID: 15007002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radio-frequency ablation of arrhythmias following congenital heart surgery.
    Kalarus Z; Kowalski O; Lenarczyk R; Pruszkowska-Skrzep P; Pluta S; Zeifert B; Chodór B; Białkowski J; Skalski J; Zembala M
    Kardiol Pol; 2006 Dec; 64(12):1343-8; discussion 1349. PubMed ID: 17206537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy.
    Marchlinski FE; Zado E; Dixit S; Gerstenfeld E; Callans DJ; Hsia H; Lin D; Nayak H; Russo A; Pulliam W
    Circulation; 2004 Oct; 110(16):2293-8. PubMed ID: 15477406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy: Prevalence, echocardiographic predictors, and treatment.
    Cardona-Guarache R; Åström-Aneq M; Oesterle A; Asirvatham R; Svetlichnaya J; Marcus GM; Gerstenfeld EP; Klein L; Scheinman MM
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1801-1810. PubMed ID: 31310380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.